TITLE

NICE'S simplified approach can't not work

AUTHOR(S)
Hird, Magnus I.
PUB. DATE
June 2008
SOURCE
BMJ: British Medical Journal (International Edition);6/28/2008, Vol. 336 Issue 7659, p1454
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "NICE's simplified approach to lipids will not work," by S.J. Laurie in the May 31, 2008 issue.
ACCESSION #
33010944

 

Related Articles

  • GPs must talk to NICE before it's too late. Summerton, Nick // Pulse;12/17/2008, Vol. 68 Issue 44, p18 

    A letter to the editor is presented which discusses the guidelines from the National Institute for Health & Clinical Excellence in Great Britain.

  • NICE rules must be backed up by training. Sheik, Sanaulla // Pulse;12/17/2008, Vol. 68 Issue 44, p18 

    A letter to the editor is presented which discusses the need to have training to support the guidance of the NATIONAL Institute for Health & Clinical Excellence in Great Britain.

  • Balancing local and national priorities is not new. Dillon, Andrew; Littlejohns, Peter // BMJ: British Medical Journal (International Edition);12/9/2006, Vol. 333 Issue 7580, p1219 

    A letter to the editor is presented in response to the article "How Much Will Herceptin Really Cost?" by A. Barrett, T. Roques, M. Small, and R. D. Smith, published in the November 25, 2006 issue.

  • The money is already there. Minhas, Robin // BMJ: British Medical Journal (International Edition);12/9/2006, Vol. 333 Issue 7580, p1219 

    A letter to the editor is presented in response to the article "How Much Will Herceptin Really Cost?" by A. Barrett, T. Roques, M. Small, and R. D. Smith, published in the November 25, 2006 issue.

  • Summary of other responses. Twisselmann, Birte // BMJ: British Medical Journal (International Edition);12/9/2006, Vol. 333 Issue 7580, p1219 

    A summary of letters to the editor is presented in response to the article "How Much Will Herceptin Really Cost?" by A. Barrett, T. Roques, M. Small, and R. D. Smith, published in the November 25, 2006 issue.

  • NICE guidance does not tally with clinical practice–a district general experience. ADIMULAM, S.; HALSEY, J.; GREENBANK, C.; BUKHARI, M. // Rheumatology;Feb2008, Vol. 47 Issue 2, p222 

    A letter to the editor is presented in response to the guidance issued by the National Institute for Health and Clinical Excellence (NICE) on rheumatology.

  • European cooperation could help to lower drug prices. Heymann, Timothy D. // BMJ: British Medical Journal (International Edition);9/13/2008, Vol. 337 Issue 7670, p591 

    A letter to the editor is presented in response to the article "NICE is Accused of Jockeying for Position in New Drug Pricing Scheme" by M. Day in the August 22, 2008 issue.

  • Who will fund GPs attending committees? Mimnagh, Andrew // Pulse;5/5/2010, Vol. 70 Issue 15, p12 

    A letter to the editor is presented in response to the article "NICE failing on GP representation," in the May 2010 issue.

  • Women over 75 with fragility fractures should have DEXA. Ralston, Stuart H.; De'Lara, Gina; Farquhar, Donald J.; Gallacher, Stephen J.; Hannan, Jim; McLellan, Alastair R. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/13/2009, Vol. 338 Issue 7708, p1404 

    A letter to the editor is presented about the guidance issued by Great Britain National Institute for Health and Clinical Excellence (NICE) on osteoporosis.

  • NICE'S economic analysis has limitations. Phillips, Richard J.; Bosanquet, Nick // BMJ: British Medical Journal (International Edition);9/16/2006, Vol. 333 Issue 7568, p603 

    This article presents a letter to the editor in response to the article "Role of Cholinesterase Inhibitors in Dementia Care Needs Rethinking," by A. J. Pelosi, S. V. McNulty, and G. A. Jackson.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics